Manufacturers/Gilead Sciences, Inc.

Gilead Sciences, Inc.

18 drugs in NADAC|0 Generic,18 Brand

View Recalls (7)

Total Drugs

0G / 18B

Avg Price / Unit

$285.9916

$17.44 – $1098.94

Avg 7d Change

-0.05%

Across 8 drugs with changes

7d Activity

8↓10 flat

of 18 total drugs

Portfolio Price Trend

Monthly average NADAC price across all drugs

Drug Portfolio

18 drugs total, 18 shown

Drug ↕	NDC	Price	7d Change ↕	Class	Market Outlier	Therapeutic Class
HARVONI 90-400 MG TABLET LEDIPASVIR and SOFOSBUVIR	61958180101	$1098.9375 per EA	—	Brand	—	Hepatitis C Virus NS5A Inhibitor, Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor
SOVALDI 400 MG TABLET SOFOSBUVIR	61958150101	$975.3000 per EA	—	Brand	—	Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor
EPCLUSA 400 MG-100 MG TABLET Velpatasvir and Sofosbuvir	61958220101	$866.0738 per EA	-0.13%	Brand	—	Hepatitis C Virus NS5A Inhibitor, Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor
VOSEVI 400-100-100 MG TABLET SOFOSBUVIR, VELPATASVIR, and VOXILAPREVIR	61958240101	$858.6884 per EA	—	Brand	—	Hepatitis C Virus NS3/4A Protease Inhibitor, Hepatitis C Virus NS5A Inhibitor, Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor
STRIBILD TABLET elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate	61958120101	$150.4090 per EA	—	Brand	—	Cytochrome P450 3A Inhibitor, Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
GENVOYA TABLET elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide	61958190101	$143.3501 per EA	—	Brand	—	Cytochrome P450 3A Inhibitor, Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
BIKTARVY 50-200-25 MG TABLET bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate	61958250101	$136.7317 per EA	-0.01%	Brand	—	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
BIKTARVY 50-200-25 MG TABLET bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate	61958250103	$136.7317 per EA	-0.01%	Brand	—	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
BIKTARVY 30-120-15 MG TABLET bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate	61958250501	$136.6925 per EA	-0.03%	Brand	—	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
COMPLERA TABLET emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate	61958110101	$130.5185 per EA	—	Brand	—	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
ODEFSEY TABLET emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide	61958210101	$130.3509 per EA	—	Brand	—	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
DESCOVY 200-25 MG TABLET emtricitabine and tenofovir alafenamide	61958200201	$71.4275 per EA	-0.01%	Brand	—	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
DESCOVY 200-25 MG TABLET emtricitabine and tenofovir alafenamide	61958200202	$71.4275 per EA	-0.01%	Brand	—	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
DESCOVY 120-15 MG TABLET emtricitabine and tenofovir alafenamide	61958200501	$71.3937 per EA	-0.03%	Brand	—	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
TRUVADA 200 MG-300 MG TABLET emtricitabine and tenofovir disoproxil fumarate	61958070101	$59.7125 per EA	-0.14%	Brand	High Outlier	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
VEMLIDY 25 MG TABLET tenofovir alafenamide	61958230101	$51.9338 per EA	—	Brand	—	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
VIREAD 300 MG TABLET TENOFOVIR DISOPROXIL FUMARATE	61958040101	$40.7318 per EA	0.00%	Brand	High Outlier	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
EMTRIVA 200 MG CAPSULE EMTRICITABINE	61958060101	$17.4370 per EA	—	Brand	—	Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor

FDA Recalls (7)

Recalls matched by company name. Verify current status with FDA.

D-0005-2025 →

Terminated

Class I

Veklury (remdesivir) for injection, 100 mg/vial, Single-Dose Vial, Rx only, Manufactured for: Gilead Sciences, Inc., Foster City, CA 94404, NDC 61958-2901-2

Presence of Particulate Matter: Presence of glass particle.

Initiated: 9/19/2024

D-0299-2022 →

Terminated

Class I

Veklury (remdesivir) for injection, 100 mg/vial, Single-Dose Vial, Rx only, Manufactured for: Gilead Sciences, Inc., Foster City, CA 94404, NDC 61958-2901-2

Presence of Particulate Matter: investigation into a customer complaint confirmed the presence of glass particulates.

Initiated: 12/3/2021

D-0045-2015 →

Terminated

Class II

Emtriva (emtricitabine) Oral Solution, 10 mg/mL, 170 mL bottles, Rx only, Manufactured for Gilead Sciences, Inc., Foster City, CA NDC 61958-0602-1 Gilead Sciences, Inc. Foster City, CA 94404.

Defective Container; leaking around the cap

Initiated: 10/1/2014

D-0013-2015 →

Terminated

Class III

Truvada (200 mg emtricitabine and 300 mg tenofovir disoproxil fumarate) tablets, 30 count bottles, Rx only, Manufactured for Gilead Sciences, Inc. Foster City, CA 94404, NDC 61958-0701-1

Presence of Foreign Substance: Truvada was found to contain small red silicone rubber particulates.

Initiated: 9/30/2014

D-1090-2014 →

Terminated

Class III

Atripla (efavirenz 600 mg/ emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg) Tablets, 30 Tablet Bottles, Rx only. Manufactured for: Bristol-Myers Squibb & Gilead Sciences, LLC, Foster City, CA 94404. Made in Ireland. NDC 15584-0101-1. Manufactured for: Bristol-Myers-Squibb & Gilead Sciences, LLC, Foster City, CA 94404 Made in Ireland

Presence of Foreign Substance: Red Silicone Rubber Particulates are Present in Drug.

Initiated: 2/19/2014

D-821-2013 →

Terminated

Class II

AmBisome (amphotericin B) liposome for Injection, 50 mg, For Intravenous Infusion Only, Single-Use Vial, Rx Only, Marketed by: Astellas Pharma US, Inc., Northbrook, IL 60062, Manufactured by: Gilead Sciences, Inc., San Dimas, CA 91773, NDC 0469-3051-30.

Lack of Sterility Assurance; During a routine simulation of the manufacturing of AmBisome, a bacterial contamination was detected in some media fill units. No contaminated batches have actually been identified in the finished product, but there is a possibility of contamination.

Initiated: 6/20/2013

D-324-2013 →

Terminated

Class I

Vistide (cidofovir) Injection, 375 mg (75 mg/mL), 5 mL single-use vial, Rx only, Manufactured for: Gilead Sciences, Inc., Foster City, CA 94404, UPC 3 61958 01011 5; NDC 61958-0101-1.

Presence of Particulate Matter: Particulate matter was found in some vials of Vistide (cidofovir injection).

Initiated: 1/31/2013